Homepage | Forward to a Friend | Make a Donation |
|
eLetter #951 | January 7, 2022 |
|
|
Strategic Plan Update
ZOOM: January 13, 2022; 2 PM Eastern
Join CEO Mary J. Wheatley to hear an update on the Foundation's strategic plan. Learn about progress in our exciting work to strengthen our organization and to build capacity for growth in support of individuals affected by scleroderma, to expand our education programs, and to build greater resources for research funding.
REGISTER
|
|
BIPOC Scleroderma Support Group
ZOOM: January 16, 2022; 4 - 5 PM Eastern
Join our facilitators, Christy, Demi, Demetra, Erion, Eva, Marilyn, and Sy, for a discussion on economic disparities and resources that may help you navigate your scleroderma journey.
After registering, you will receive a confirmation email containing information about joining the meeting.
REGISTER
|
Scleroderma Vascular Disease Working Group |
Share Your Experiences of Raynaud and Digital Ulcers
Individuals who have scleroderma and experience Raynaud Phenomenon and digital ulcers are invited to participate in a study led by the Scleroderma Vascular Disease Working Group of OMERACT, an international initiative of health professionals established in 1992 to improve outcome measurement in rheumatology.
All answers are confidential. The survey takes 20 minutes to complete. You must be 18 or older, have scleroderma, and experience Raynaud Phenomenon with or without digital ulcers. There are two rounds of the survey, January 17 and mid-February.
SURVEY
|
|
Help Our Friends Pick a New Logo
Our friends at the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) have grown and are establishing their own visual identity. Your input will help them decide on their new logo. Follow the link below to give feedback on three logo options. (RDCA-DAP is an FDA-funded partnership led by Critical Path Institute and NORD.)
SURVEY
|
|
If You Need Health Insurance, Don't Miss the January 15 Deadline
You can still enroll in or change 2022 Marketplace health insurance right now on HealthCare.gov.
If you enroll or change a current plan by January 15, 2022, coverage will start February 1, 2022. After January 15, you can only enroll or change plans if you qualify for a Special Enrollment Period.
HEALTHCARE.GOV
|
|
Scleroderma 101: Newly Diagnosed
VIDEO: Recorded July 2021
Watch "Scleroderma 101: Newly Diagnosed," a presentation by Flavia Castelino, MD, recorded during the 2021 virtual National Scleroderma Conference. Dr. Castelino reviews the different types of scleroderma (localized versus systemic forms), with a primary focus on systemic sclerosis. Also discussed are the various clinical manifestations of systemic sclerosis, what to expect at your rheumatology visit, and an overview of the different treatment options available.
WATCH
|
|
Transition From Pediatric to Adult Cure
VIDEO: Recorded October 2021
Watch this presentation from the 2021 virtual Kids Get Scleroderma, Too! conference with Vidya Sivaraman, MD, of Nationwide Children's Hospital in Columbus, Ohio. Dr. Sivaraman discusses transition from pediatric to adult care, which involves significant movement in the parent-child relationship as the parent transfers responsibility for care to the child.
WATCH
|
Advertisement |
|
Advertisement |
|
|
|
|
|
|
Disclaimer: The National Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
|
|
|